DCGI Orders Action, Warns of Drug Shortages

The Indian government is cracking down on drug companies that aren't following the rules.

The Drug Controller General of India (DCGI) is telling states to take action against companies that sell drugs made by manufacturers who failed inspections.

Some marketers have listed fake addresses.

The government is worried about the quality of medicines, and the new rules hold both manufacturers and marketers responsible.

This might cause medicine shortages because some manufacturers may have to stop making drugs.

Industry insiders have concerns.

Regulators are trying to ensure drugs are safe, but this may disrupt the supply.